Generics 20

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Terazosin manufacturers

20 products found

Filters

Filters

Filters , active

Country of origin : Macedonia

Clear all

20 products found

terazosin

Tablets 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16496
It is part of the Pharmaceutical and Medicine Manufacturing Industry and is located in the European market. The corporation makes over $6.00 million in revenue (USD). They specialize in urological goods, making them the first Spanish pharmaceutical laboratory to operate in the country with its facilities. Years later, the company introduced an allergic product range.

terazosin

Tablets 1 mg, 2 mg, 5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Hytrin (Abbott)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 38 days

terazosin

Tablets 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16192
A pharmaceutical manufacturer based in LATAM that is active in dermatology, urology, and respiratory for 20+ years.

Manufacturer usually replies in 11 days

Want to see all 20 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Terazosin is a medication used to relieve the symptoms of enlarged prostate and hypertension. Suppliers of terazosin market it in the form of 1mg, 2mg, 5mg, and 10mg oral tablets. The drug was first introduced into the market in 1985 under the trade name Hytrin by developer and earliest manufacturer of terazosin – Abbot Pharmaceuticals. Abbot continues to hold the largest share of the terazosin market, however, other manufacturers and suppliers have since introduced their formulations of the medication. Other major pharmaceutical manufacturers of terazosin currently include Boston Scientific, Vascular Medical, and MicroPort, whereas major suppliers are companies Mylan, Teva and Sandoz. Terazosin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified terazosin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.